Application 204595
- Type
- ANDA
- Sponsor
- ALVOGEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FELBAMATE | FELBAMATE | TABLET;ORAL | 400MG | No | No |
| 002 | FELBAMATE | FELBAMATE | TABLET;ORAL | 600MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47781-550 | Felbamate | felbamate | Alvogen Inc. | ANDA | Current |
| 47781-550 | Felbamate | felbamate | Alvogen Inc. | ANDA | Current |
| 47781-551 | Felbamate | felbamate | Alvogen Inc. | ANDA | Current |
| 47781-551 | Felbamate | felbamate | Alvogen Inc. | ANDA | Current |
| 47781-627 | Felbamate | felbamate | Alvogen Inc. | ANDA | Current |
| 47781-627 | Felbamate | felbamate | Alvogen Inc. | ANDA | Current |
| 47781-627 | Felbamate | felbamate | Alvogen Inc. | ANDA | Current |
| 47781-627 | Felbamate | felbamate | Alvogen Inc. | ANDA | Current |
| 47781-630 | Felbamate | felbamate | Alvogen Inc. | ANDA | Current |
| 47781-630 | Felbamate | felbamate | Alvogen Inc. | ANDA | Current |
| 47781-630 | Felbamate | felbamate | Alvogen Inc. | ANDA | Current |
| 47781-630 | Felbamate | felbamate | Alvogen Inc. | ANDA | Current |